The estimated Net Worth of Harry Jr. Thomasian is at least $288 mil dollars as of 5 April 2024. Mr Thomasian owns over 135,714 units of Precigen Inc stock worth over $287,862 and over the last 3 years he sold PGEN stock worth over $0.
Mr has made over 10 trades of the Precigen Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 135,714 units of PGEN stock worth $131,643 on 5 April 2024.
The largest trade he's ever made was exercising 135,714 units of Precigen Inc stock on 5 April 2024 worth over $131,643. On average, Mr trades about 22,067 units every 57 days since 2021. As of 5 April 2024 he still owns at least 296,765 units of Precigen Inc stock.
You can see the complete history of Mr Thomasian stock trades at the bottom of the page.
Harry Thomasian Jr. is the Chief Financial Officer at Precigen Inc.
Over the last 5 years, insiders at Precigen Inc have traded over $44,216,787 worth of Precigen Inc stock and bought 52,689,457 units worth $114,197,137 . The most active insiders traders include Randal J Kirk, Trading S.A. Ares y Helen Sabzevari. On average, Precigen Inc executives and independent directors trade stock every 9 days with the average trade being worth of $358,866. The most recent stock trade was executed by Randal J Kirk on 9 August 2024, trading 23,529,411 units of PGEN stock currently worth $19,999,999.
precigen, inc. discovers and develops the next generation of gene and cellular therapies in the united states. it also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; proprietary methane bioconversion platform that turns natural gas into energy and chemical products; and reproductive and embryo transfer technologies. in addition, the company offers ultravector platform that incorporates advanced dna construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbil15, a gene that enhances functional characteristics of immune cells; sleeping beauty, a non-viral transposon/transposase system; attsite recombinases, which breaks and rejoins dna at specific sequences; adenoverse technology platform, a library of engineered adenovector serotypes; and l. lactis is a food-grade bacterium. additionally, it provides rheoswitch inducible gene switch that provides qua
Precigen Inc executives and other stock owners filed with the SEC include: